Atlas Arteria (ASX:ALX) has escalated its defence against an unsolicited takeover with a fresh ASX announcement, lodging its Fourth Supplementary Target's Statement and reaffirming the Independent Directors' recommendation that securityholders REJECT the off-market offer from a subsidiary of IFM Global Infrastructure Fund. For holders of this ASX infrastructure stock, the document is the latest move in an increasingly active contest for control of one of the country's larger listed toll-road owners.

The announcement is notable because it directly responds to the bidder's most recent statement and lays out, in detail, why the board believes the current offer falls short. With the offer period scheduled to close on 25 June 2026, the timing of this investor update places it at a critical decision point for securityholders weighing whether to accept, reject or simply do nothing.

What the ASX Announcement Says

In its ASX announcement, Atlas Arteria (ASX: ALX) said it has lodged a Fourth Supplementary Target's Statement in response to the Eighth Supplementary Bidder's Statement released by the bidder, Diamond Infraco 1 Pty Ltd, a wholly owned subsidiary of IFM Global Infrastructure Fund. The document supplements the original Target's Statement dated 26 May 2026 and three earlier supplementary statements.

The core message is unchanged: the Independent Directors continue to unanimously recommend that securityholders REJECT the offer, which they describe as too low and opportunistic. The board states the offer materially undervalues Atlas Arteria and does not reflect an appropriate control premium, noting it sits 12% below the $5.79 midpoint of the Independent Expert's valuation range of $5.39 to $6.20 per security. To reject, the company advises securityholders simply to ignore documents sent by the bidder.

The statement also addresses the bidder's guidance that it will not pay more than A$5.10 per security for at least 12 months after the offer closes, absent a competing proposal. Atlas Arteria argues this does not preclude securityholders from receiving more than $5.10 through other structures, and it points to alternative value-creation routes including asset sales and distributions.

Why This Matters for Investors

For investors, a contested takeover is one of the most consequential events a listed company can face, because it forces a direct choice about whether to crystallise value now or hold for a potentially higher outcome later. The Atlas Arteria board's firm rejection signals its view that the offer undervalues the business, and the reference to an independent expert's valuation range provides a benchmark that market participants may consider against the bid price.

The announcement matters because it sharpens the competing arguments at the precise moment securityholders must decide. The board is effectively asking holders to back its judgement that the assets are worth more than $5.10 per security, while the bidder is presenting a cash exit. How securityholders weigh certainty of cash today against the board's value case is central to the outcome.

There is also a tactical dimension that affects all holders. The board highlights that the bidder can now buy on-market and raises the prospect of securityholders restricting stock lending to limit the bidder's voting power, which underscores how the mechanics of the contest could influence the final result.

Key Details from the Announcement

Several specific points anchor the board's case. First, on price, the Independent Directors stress the offer is 12% below the $5.79 valuation midpoint and does not deliver an appropriate control premium. Second, on the bidder's intentions, they note that while IFM has said it will not pay above $5.10 for 12 months and that this cap would be reduced by any distributions paid in that period, those statements do not prevent transactions, such as a buy-back or capital reduction, in which holders could ultimately receive more than $5.10.

Third, the board points to alternative paths to value. Atlas Arteria says it has attracted interest in its underlying portfolio of assets and continues to explore potential divestments, with net cash proceeds from any sales available to be returned to securityholders. It also reconfirms ordinary distribution guidance of 40.0 cents per security for 2026 and a target of at least that level, and reserves the right to bring forward or pay additional distributions.

Fourth, the statement cites IFM's track record of paying more than its initial offer price in prior transactions, referencing examples including Aleatica, Vienna Airport and Sydney Airport, where final prices exceeded opening bids. The board also highlights a Director Representation Agreement that constrains the bidder's conduct regardless of its stake, which it frames as a further reason the bidder may need to pay more to acquire full control.

Market and Sector Context

Toll-road and core infrastructure assets are prized by large institutional investors, including pension and superannuation-backed funds, because they typically generate stable, inflation-linked cash flows over long concession lives. That appeal helps explain why an infrastructure fund would pursue Atlas Arteria, whose portfolio spans toll roads in France, Germany and the United States, including a major interest in the APRR motorway network and stakes in the Chicago Skyway and Dulles Greenway.

Takeover activity in the ASX infrastructure space often reflects the gap between public-market valuations and the prices private capital is willing to pay for long-duration assets. When listed infrastructure trades below the value strategic acquirers ascribe to the underlying assets, it can attract bids, and boards frequently argue that opening offers understate intrinsic value, which is the dynamic on display here.

For Australian shares investors, contested bids for infrastructure names are closely watched because they test the market's view of asset value and can influence sentiment toward comparable listed entities. The presence of an independent expert's valuation range and references to precedent transactions are typical features of these contests.

Potential Opportunities

The clearest opportunity the board is putting forward is the prospect of a higher outcome than the current offer. By citing IFM's history of raising prices in past situations and by keeping alternative routes, such as asset sales and capital returns, on the table, Atlas Arteria is signalling that holding may deliver more value than accepting $5.10 per security. Market participants may weigh whether a revised bid or competing proposal could emerge.

The reaffirmed distribution guidance of 40.0 cents per security for 2026, with a target of at least that level and the flexibility to bring forward or add to distributions, represents a tangible income consideration for holders who choose to remain invested. For an infrastructure asset, distribution durability is a core part of the investment case.

Potential divestment of portfolio assets at values aligned with the independent expert's report, with net proceeds available for return to securityholders, is another avenue the board highlights as a way to deliver value outside the takeover. Whether any such transactions materialise is uncertain, but they form part of the opportunity set the board is presenting.

Key Risks to Watch

A central risk for securityholders who follow the board's recommendation is that no higher offer or alternative transaction eventuates. If the bidder declines to raise its price and stands by its stated cap, holders who reject may find the most accessible exit is at or below $5.10, and the security's trading price after the offer closes is uncertain.

There are also structural risks in a contested bid. The bidder's ability to buy on-market and the dynamics of stock lending could affect its voting power and the eventual control outcome. The offer period can be extended automatically if the bidder's voting power passes 50%, which adds uncertainty around timing and the final landscape.

More broadly, the value case rests on assumptions about asset values, distribution sustainability and the feasibility of divestments, none of which are guaranteed. Atlas Arteria's own materials encourage holders to read all statements in full and seek independent advice, reflecting the genuine uncertainty inherent in deciding how to respond to the offer.

What Could Happen Next

The most immediate date to watch is the scheduled close of the offer period at 7.00pm on 25 June 2026, unless it is withdrawn or extended. Securityholders will need to decide before then whether to accept or reject, and the board has made clear that taking no action constitutes rejection.

Investors may watch for any further supplementary statements from either side, any revision to the offer price, and any sign of a competing proposal. Updates on potential asset divestments or on distribution timing could also influence how holders assess the relative merits of accepting versus holding.

The bidder's level of acceptances and any change in its voting power will be important signals, particularly given the provision that crossing 50% would automatically extend the offer. Market participants may also monitor commentary around stock lending and any action before the Takeovers Panel, which the company has reserved its rights to pursue.

Conclusion

The Fourth Supplementary Target's Statement underscores that the Atlas Arteria (ASX: ALX) board remains resolute in urging securityholders to REJECT the IFM offer, arguing it materially undervalues the company and does not reflect a fair control premium. The board reinforces its case with the independent expert's valuation range, references to IFM's history of raising prices, reaffirmed distribution guidance and the prospect of value-accretive asset sales.

For holders of this ASX infrastructure stock, the decision ultimately balances the certainty of a cash exit against the board's view that more value can be realised by holding. With the offer period closing on 25 June 2026, the announcement arrives at a decisive moment, and balanced observers will note that while the board presents a compelling value argument, the outcome and any prospect of a higher price remain uncertain.